Published in Clin Exp Immunol on March 01, 1982
Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology (2007) 1.21
Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression. J Virol (2003) 1.10
Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol (2007) 0.96
Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J Virol (2000) 0.81
Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens? Clin Exp Immunol (1983) 0.81
Pneumocystosis associated with canine distemper virus infection in a mink. Can Vet J (1999) 0.76
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Infection, anergy and cell-mediated immunity. N Engl J Med (1975) 2.45
Replication and persistence of measles virus in defined subpopulations of human leukocytes. J Virol (1975) 2.30
Effect of measles vaccine on immunologic responsiveness. Pediatrics (1969) 2.08
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med (1975) 1.86
Combined detection of human T and B lymphocytes by rosette formation with sheep erythrocytes and zymosan-C3 complexes. J Immunol (1974) 1.61
Abnormalities in lymphocyte proliferation in classical and atypical measles infection. Cell Immunol (1973) 1.42
The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity. J Immunol (1974) 1.40
Relationships among measles, canine distemper and rinderpest viruses. Prog Med Virol (1968) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Immunological recovery after measles. Clin Exp Immunol (1978) 1.17
Dissociation of lymphokine production and blastogenesis in children with measles infections. Clin Immunol Immunopathol (1978) 1.16
Immune responses during measles infection in immunosuppressed Rhesus monkeys. J Immunol (1977) 1.10
Experimental canine distemper virus-induced lymphoid depletion. Am J Pathol (1974) 1.09
Susceptibility of mice to acute and persistent measles infection. Infect Immun (1978) 1.00
Receptors for IgG (Fc receptors) on human lymphocytes: re-evaluation by multiple techniques. Clin Exp Immunol (1978) 0.96
Suppression of the histoplasmin reaction with measles and smallpox vaccines. Am J Dis Child (1968) 0.95
Influenza in ferrets and guinea pigs: effect on cell-mediated immunity. Infect Immun (1978) 0.88
A canine distemper model of virus-induced anergy. J Infect Dis (1976) 0.80
Lymphocyte blast transformation responses in measles infection. Scand J Immunol (1980) 0.80
Lymphocyte subpopulations in the ferret. Dev Comp Immunol (1981) 0.79
Replication of measles virus in continuous lymphoid cell lines. J Immunol (1976) 0.79
Cell-mediated immunity in ferrets. Delayed dermal hypersensitivity, lymphocyte transformation, and macrophage migration inhibitory factor production. Dev Comp Immunol (1981) 0.78
Cell-mediated immunity in measles using the leucocyte migration test. Int Arch Allergy Appl Immunol (1978) 0.78
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis (1991) 3.88
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.03
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol (1995) 2.54
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis (2007) 2.09
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Tibial stress reaction in runners. Correlation of clinical symptoms and scintigraphy with a new magnetic resonance imaging grading system. Am J Sports Med (1995) 2.08
Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.08
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol (1990) 1.90
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Coincident development of sesamoid bones and clues to their evolution. Anat Rec (1999) 1.64
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. J Infect Dis (1988) 1.60
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med (1973) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med (1987) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Torulopsis glabrata renal infection. Am J Med (1974) 1.48
Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother (1990) 1.45
Risk factors for colonization with yeast species in a Veterans Affairs long-term care facility. J Am Geriatr Soc (1998) 1.45
Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.43
Intermittent urethral catheterization in the elderly. J Am Geriatr Soc (1989) 1.43
Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin Infect Dis (1992) 1.42
Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother (1977) 1.42
Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother (1992) 1.40
Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1995) 1.37
Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control (1987) 1.36
Cryptococcus laurentii lung abscess. Am Rev Respir Dis (1981) 1.35
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 1.32
Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity. J Clin Microbiol (1980) 1.30
Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother (1988) 1.29
Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc (1994) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Cardiobacterium hominis endocarditis: Two cases and a review of the literature. Eur J Clin Microbiol Infect Dis (2006) 1.28
Evaluation of the BACTEC antimicrobial removal system for detection of bacteremia. J Clin Microbiol (1983) 1.27
Association of glenoid labral cysts with labral tears and glenohumeral instability: radiologic findings and clinical significance. Radiology (1994) 1.22
Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.21
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis (2008) 1.20
Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses (1999) 1.20
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Salmonella meningitis. Occurrence in an adult. Arch Neurol (1979) 1.13
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Tuberculous tenosynovitis of the flexor tendons of the wrist: MR imaging with pathologic correlation. Skeletal Radiol (1996) 1.13
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin. Am J Med (1990) 1.12
Bilateral stress fractures of the anterior part of the tibial cortex. A case report. J Bone Joint Surg Am (2000) 1.11
Detection of cryptococcal antigen. Comparison of two latex agglutination tests. Am J Clin Pathol (1981) 1.11
Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol (1995) 1.10
Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters. Mycoses (1993) 1.10
Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect Dis (2001) 1.10
Hospital-acquired infective endocarditis. Arch Intern Med (1988) 1.09
Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses (2001) 1.09
MR imaging of cyclops lesions. AJR Am J Roentgenol (2000) 1.08
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1994) 1.07
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays. J Clin Microbiol (1995) 1.06
Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol (1975) 1.06
Meniscal tears of the knee: accuracy of detection with fast spin-echo MR imaging and arthroscopic correlation in 293 patients. Radiology (1997) 1.05
Simple assay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother (1976) 1.05
Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis (2001) 1.05
Recurrent pseudobacteremias traced to a radiometric blood culture device. Infect Control (1987) 1.05
Nosocomial infection with gentamicin-carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.04
Cryptococcal endophthalmitis: case report and review. Clin Infect Dis (1992) 1.04
Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers. Clin Infect Dis (2001) 1.03
Antimicrobial resistance of Haemophilus species in patients with chronic bronchitis. Am Rev Respir Dis (1979) 1.03
Candidiasis. A diagnostic and therapeutic challenge. Postgrad Med (1986) 1.03
Mucormycosis: association with deferoxamine therapy. Am J Med (1989) 1.02
Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol (1997) 1.01
Long-term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface. Infect Control Hosp Epidemiol (1996) 1.01
Septic arthritis in the elderly. J Am Geriatr Soc (1985) 1.00
Prosthetic joint infections in the elderly. Am J Med (1990) 1.00
Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium. Diagn Microbiol Infect Dis (1996) 0.99
Chronic candidal meningitis: an uncommon manifestation of candidiasis. Clin Infect Dis (1994) 0.98
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis (2001) 0.98
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin. Diagn Microbiol Infect Dis (1995) 0.98
Invasive fungal infections in patients with chronic mucocutaneous candidiasis. Arch Intern Med (1981) 0.98
Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J Med (1993) 0.97
Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1997) 0.97
Localization of specific joint causing hindfoot pain: value of injecting local anesthetics into individual joints during arthrography. AJR Am J Roentgenol (1995) 0.97
Influenza virus infection of the guinea pig: immune response and resistance. Med Microbiol Immunol (1979) 0.97
Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora. Am J Med (1983) 0.97